{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:26:10Z","timestamp":1793042770666,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100019331","name":"Henan Medical Science and Technique Foundation","doi-asserted-by":"publisher","award":["SBGJ202103075"],"award-info":[{"award-number":["SBGJ202103075"]}],"id":[{"id":"10.13039\/501100019331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515012714"],"award-info":[{"award-number":["2024A1515012714"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U23A20500"],"award-info":[{"award-number":["U23A20500"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374011"],"award-info":[{"award-number":["82374011"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.cbi.2025.111471","type":"journal-article","created":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T18:48:48Z","timestamp":1741459728000},"page":"111471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Farnesoid X receptor regulates CYP1A1 and CYP1B1 and estradiol metabolism in mouse and human cell lines"],"prefix":"10.1016","volume":"412","author":[{"given":"Chanjuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zubao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meixia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangliang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinsheng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zifei","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cbi.2025.111471_bib1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41419-024-06495-y","article-title":"Farnesoid X receptor promotes non-small cell lung cancer metastasis by activating Jak2\/STAT3 signaling via transactivation of IL-6ST and IL-6 genes","volume":"15","author":"Jin","year":"2024","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.cbi.2025.111471_bib2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.molmed.2007.06.001","article-title":"Targeting farnesoid X receptor for liver and metabolic disorders","volume":"13","author":"Fiorucci","year":"2007","journal-title":"Trends Mol. Med."},{"issue":"4","key":"10.1016\/j.cbi.2025.111471_bib3","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/hep.27964","article-title":"Negative feedback regulation of bile acid metabolism: impact on liver metabolism and diseases","volume":"62","author":"Chiang","year":"2015","journal-title":"Hepatology"},{"issue":"33","key":"10.1016\/j.cbi.2025.111471_bib4","doi-asserted-by":"crossref","first-page":"12759","DOI":"10.1074\/jbc.RA118.001789","article-title":"Cholestasis-induced bile acid elevates estrogen level via farnesoid X receptor mediated suppression of the estrogen sulfotransferase SULT1E1","volume":"293","author":"Liu","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.cbi.2025.111471_bib5","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/cr.2008.289","article-title":"FXR: a metabolic regulator and cell protector","volume":"18","author":"Wang","year":"2008","journal-title":"Cell Res."},{"issue":"11","key":"10.1016\/j.cbi.2025.111471_bib6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11892-018-1092-3","article-title":"Rethinking bile acid metabolism and signaling for type 2 diabetes treatment","volume":"18","author":"Zaborska","year":"2018","journal-title":"Curr. Diabetes Rep."},{"key":"10.1016\/j.cbi.2025.111471_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175808","article-title":"Diosgenin attenuates nonalcoholic hepatic steatosis through the hepatic FXR-SHP-SREBP1C\/PPAR\u03b1\/CD36 pathway","volume":"952","author":"Chen","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111471_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2021.101094","article-title":"Bile acids and their receptors in metabolic disorders","volume":"82","author":"Fiorucci","year":"2021","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.cbi.2025.111471_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2022.111678","article-title":"Recent advances on FXR-targeting therapeutics","volume":"552","author":"Panzitt","year":"2022","journal-title":"Mol. Cell. Endocrinol."},{"issue":"7","key":"10.1016\/j.cbi.2025.111471_bib10","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1124\/dmd.104.003061","article-title":"Lithocholic acid decreases expression of UGT2B7 in CACO-2 cells: a potential role for a negative farnesoid X receptor response element","volume":"33","author":"Lu","year":"2005","journal-title":"Drug Metabol. Dispos."},{"issue":"9","key":"10.1016\/j.cbi.2025.111471_bib11","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1021\/acs.molpharmaceut.6b01103","article-title":"Transcriptional regulation of human UDP-glucuronosyltransferase 2B10 by farnesoid X receptor in human hepatoma HepG2 cells","volume":"14","author":"Lu","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.cbi.2025.111471_bib12","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.bcp.2017.08.023","article-title":"Farnesoid X receptor regulates SULT1E1 expression through inhibition of PGC1\u03b1 binding to HNF4\u03b1","volume":"145","author":"Wang","year":"2017","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.cbi.2025.111471_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/03602532.2012.748794","article-title":"Regulation of the cytosolic sulfotransferases by nuclear receptors","volume":"45","author":"Runge-Morris","year":"2013","journal-title":"Drug Metab. Rev."},{"issue":"4","key":"10.1016\/j.cbi.2025.111471_bib14","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jhep.2010.01.010","article-title":"Regulation of the human bile acid UDP-glucuronosyltransferase 1A3 by the farnesoid X receptor and bile acids","volume":"52","author":"Erichsen","year":"2010","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.cbi.2025.111471_bib15","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1124\/dmd.114.062836","article-title":"GW4064, an agonist of farnesoid X receptor, represses CYP3A4 expression in human hepatocytes by inducing small heterodimer partner expression","volume":"43","author":"Zhang","year":"2015","journal-title":"Drug Metabol. Dispos."},{"issue":"6","key":"10.1016\/j.cbi.2025.111471_bib16","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1002\/hep.27280","article-title":"Estradiol, farnesoid X receptor, and altered metabolism in pregnancy","volume":"60","author":"Abu-Hayyeh","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cbi.2025.111471_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2022.106182","article-title":"Inhibition of estrogen sulfation by Xian-Ling-Gu-Bao capsule","volume":"225","author":"He","year":"2023","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.cbi.2025.111471_bib18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jare.2022.06.006","article-title":"Naringenin in Si-Ni-San formula inhibits chronic psychological stress-induced breast cancer growth and metastasis by modulating estrogen metabolism through FXR\/EST pathway","volume":"47","author":"Zhang","year":"2023","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.cbi.2025.111471_bib19","article-title":"Identification of naturally occurring inhibitors in Xian-Ling-Gu-Bao capsule against the glucuronidation of estrogens","volume":"13","author":"He","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.cbi.2025.111471_bib20","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1039\/C7FO01298E","volume":"9","author":"Qin","year":"2018","journal-title":"Food Funct."},{"issue":"3","key":"10.1016\/j.cbi.2025.111471_bib21","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1124\/dmd.123.001490","article-title":"Dihydrotanshinone I\u2013induced CYP1 enzyme inhibition and alteration of estradiol metabolism","volume":"52","author":"Liu","year":"2024","journal-title":"Drug Metabol. Dispos."},{"issue":"2","key":"10.1016\/j.cbi.2025.111471_bib22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.canlet.2004.10.007","article-title":"Cytochrome P450-mediated metabolism of estrogens and its regulation in human","volume":"227","author":"Tsuchiya","year":"2005","journal-title":"Cancer Lett."},{"issue":"2, Part A","key":"10.1016\/j.cbi.2025.111471_bib23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.canlet.2014.04.018","article-title":"Estrogen metabolism and breast cancer","volume":"356","author":"Samavat","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cbi.2025.111471_bib24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bcp.2019.02.026","article-title":"The transcription factor E4bp4 regulates the expression and activity of Cyp3a11 in mice","volume":"163","author":"Tong","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111471_bib25","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3389\/fphar.2019.00496","article-title":"The efflux mechanism of fraxetin-O-glucuronides in ugt1a9-transfected HeLa cells: identification of multidrug resistance-associated proteins 3 and 4 (MRP3\/4) as the important contributors","volume":"10","author":"Qin","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.cbi.2025.111471_bib26","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/00498254.2017.1323139","article-title":"Glucuronidation of icaritin by human liver microsomes, human intestine microsomes and expressed UDP-glucuronosyltransferase enzymes: identification of UGT1A3, 1A9 and 2B7 as the main contributing enzymes","volume":"48","author":"Wang","year":"2018","journal-title":"Xenobiotica"},{"key":"10.1016\/j.cbi.2025.111471_bib27","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jpba.2018.03.047","article-title":"Metabolic profiling of corylin in vivo and in vitro","volume":"155","author":"Qin","year":"2018","journal-title":"J. Pharmaceut. Biomed. Anal."},{"issue":"9","key":"10.1016\/j.cbi.2025.111471_bib28","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1053\/meta.2001.25592","article-title":"Role of human cytochrome P450 1A1, 1A2, 1B1, and 3A4 in the 2-, 4-, and 16[alpha ]-hydroxylation of 17[beta ]-estradiol","volume":"50","author":"Badawi","year":"2001","journal-title":"Metab., Clin. Exp."},{"key":"10.1016\/j.cbi.2025.111471_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115843","article-title":"CRY1\/2 regulate rhythmic CYP2A5 in mouse liver through repression of E4BP4","volume":"217","author":"Lin","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111471_bib30","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jpba.2018.06.022","article-title":"In vitrometabolic mapping of neobavaisoflavone in human cytochromes P450 and UDP-glucuronosyltransferase enzymes by ultra high-performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry","volume":"158","author":"Xu","year":"2018","journal-title":"J. Pharmaceut. Biomed. Anal."},{"issue":"12","key":"10.1016\/j.cbi.2025.111471_bib31","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1016\/j.bcp.2003.08.019","article-title":"Transient induction of cytochromes P450 1A1 and 1B1 in MCF-7 human breast cancer cells by indirubin","volume":"66","author":"Spink","year":"2003","journal-title":"Biochem. Pharmacol."},{"issue":"10","key":"10.1016\/j.cbi.2025.111471_bib32","first-page":"3942","article-title":"Differential regulation of cytochrome P450 1A1 and 1B1 by a combination of dioxin and pesticides in the breast tumor cell line MCF-71","volume":"61","author":"Coumoul","year":"2001","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.cbi.2025.111471_bib33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10549-007-9535-6","article-title":"Farnesol, a mevalonate pathway intermediate, stimulates MCF-7 breast cancer cell growth through farnesoid-X-receptor-mediated estrogen receptor activation","volume":"107","author":"Journe","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.cbi.2025.111471_bib34","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/1097-0045(20000615)44:1<26::AID-PROS4>3.0.CO;2-P","article-title":"Pharmacodynamic model of testosterone suppression after intramuscular depot estrogen therapy in prostate cancer","volume":"44","author":"Johansson","year":"2000","journal-title":"Prostate"},{"issue":"2","key":"10.1016\/j.cbi.2025.111471_bib35","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/(SICI)1097-0045(19990701)40:2<76::AID-PROS2>3.0.CO;2-Q","article-title":"Time for revival of estrogens in the treatment of advanced prostatic carcinoma? Pharmacokinetics, and endocrine and clinical effects, of a parenteral estrogen regimen","volume":"40","author":"Henriksson","year":"1999","journal-title":"Prostate"},{"key":"10.1016\/j.cbi.2025.111471_bib36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cbi.2018.09.001","article-title":"The roles of breast cancer resistance protein (BCRP\/ABCG2) and multidrug resistance-associated proteins (MRPs\/ABCCs) in the excretion of cycloicaritin-3-O-glucoronide in UGT1A1-overexpressing HeLa cells","volume":"296","author":"Li","year":"2018","journal-title":"Chem. Biol. Interact."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279725001012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279725001012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T19:51:03Z","timestamp":1762113063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279725001012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":36,"alternative-id":["S0009279725001012"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2025.111471","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Farnesoid X receptor regulates CYP1A1 and CYP1B1 and estradiol metabolism in mouse and human cell lines","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2025.111471","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111471"}}